Abstract Submission

Abstracts can only be submitted online via the abstract submission form.

Abstracts sent by post or email will not be accepted. No exceptions will be made.

• Abstracts can be saved in “Draft” status to be re-edited and modified until the submission deadline: (Wednesday 25 October 2023, 23:59 CET). Therefore, the submitter will be required to create a user account.
• Abstracts fulfilling all criteria can be saved in “Final submission” status. Only abstracts in “Final submission” status will be regarded as successfully submitted and considered for the Congress. The submitted / draft abstracts cannot be edited after the submission deadline (Wednesday 25 October 2023, 23:59 CET).
• Abstracts are accepted on a wide range of topics in haemophilia and bleeding disorders. The submitter has to select the right topic for the abstract on the submission form. Available topics are:
  • Haemophilia
    • Haemophilia – Laboratory aspects, diagnostics
    • Haemophilia – Preclinical
    • Haemophilia – Clinical
  • Von Willebrand Disease
    • Von Willebrand Disease – Laboratory aspects, diagnostics
    • Von Willebrand Disease – Preclinical
    • Von Willebrand Disease – Clinical
  • Other bleeding disorders
  • Physiotherapy
  • Nursing
  • Psycho-social aspects
• The abstract should be structured into the following sections:
  • A title which clearly indicates the nature of the investigation.
  • Introduction should contain 1-2 sentences that clearly indicate the scientific question of the study and its clinical (or other) importance.
  • Methods should contain sufficient information to be able to understand the experimental design, the analytical techniques and the statistics used in the study.
  • Results should contain objective data to answer the scientific question(s).
  • Discussions / Conclusions should provide only conclusions of the study directly supported by the results, along with implications for clinical practice, avoiding speculation and overgeneralisation.
  • No tables or figures are allowed in the abstract.
• Conflict of interest: It is the intent of EAHAD 2024 to provide high-quality sessions focused on educational content that is free from commercial influence or bias. Thus, the submitting author of an abstract is requested to declare any potential conflicts of interest for all authors during abstract submission.
• Abbreviations should be indicated in parentheses following their first mention in the text. Trade names cannot be mentioned in the title. However, trade names in brackets will be accepted in the body of the text.
• The submission of an abstract constitutes a formal commitment by the submitting (presenting) author to present the abstract (if accepted) in the session and the time assigned by the Programme Committee. Registration fees will not be waived.
• The presenting author of the abstract must be registered at the conference within 14 days of confirmation of abstract acceptance (the author will benefit from the early bird registration fee).
• Please ensure your abstract does not contain spelling, grammar, or scientific mistakes, as it will be reproduced exactly as submitted. Linguistic accuracy is your responsibility. No proofreading will be done. No changes can be made to the abstract after the submission deadline.
• Only original abstracts will be accepted and considered for the review.

• 10 abstracts will be selected by the Organising Committee to be presented orally in the SLAM session.
  Kindly note that the selection for these oral presentations is based on the scientific calibre of the abstract and its coherence with the other selected abstracts.
• EAHAD would like to promote young scientists in the SLAM session. Accordingly, if you wish to submit an abstract for an oral presentation, you will be asked to confirm that the presenting author will be 40 years old or under at the time of the congress

The internet abstract submission system works best with Internet Explorer 8.0 or higher and Mozilla Firefox 5.0 or higher and Chrome: 16 or higher.

Cookies and JavaScript need to be enabled.

Abstract submitters will be asked their professional category during the submission process.

TRAVEL GRANTS

• EAHAD will be awarding travel grants to junior doctors and researchers (under 35 years old) and allied health professionals wishing to attend EAHAD 2024. Grants are available for both European and international participants.
• The grants go towards covering registration, travel, and accommodation expenses to attend the congress (based on actual costs and receipts) and will be awarded on the basis of abstract submission, application quality and financial need.
• If you wish to be considered for a travel grant and meet the criteria, please check the corresponding box when submitting your abstract. Please note that you will be required to complete a separate online application form. Deadline for application is 8 November 2023 at 23:59 CET. 
• The awardee must come in person to get his/her grant (at the speakers’ desk). No payment will be made before or after the Congress.
• The EAHAD 2024 Organising Committee will select the travel grant recipients.

POSTER AWARDS & SLAM SESSION

• Poster sessions will be organised onsite and awards will be given to the top 3 presenters.
• 10 abstracts will be selected by the Scientific Committee to be presented orally in the SLAM session. Kindly note that the selection for these oral presentations depends mainly on the scientific match and coherence in the oral session.
• EAHAD would like to promote young scientists for the oral communications, so should you wish to submit an abstract for an oral presentation you will be requested to confirm that the presenting author is 40 years old or under at the time of the congress.